Aflibercept in Patients With Pigment Epithelial Detachments (PED)
- Sponsor
- University Hospital Muenster
- Study ID
- NCT03370380
- Status
- Completed
Conditions
- Pigment Epithelial Detachment
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Aflibercept — DRUGPatients are treated according to authorization of Aflibercept
Study Details
Uncontrolled single site non randomized non interventional study to determine the safety and efficacy of intravitreal injections of Aflibercept in patients with recent vision loss due to retinal pigment epithelial detachment secondary to AMD
Key Dates
- Start date
- Apr 17, 2015
- Status verified
- Jul 2018
- Primary completion
- Apr 23, 2018
- Completion
- Apr 23, 2018
Study Design
- Enrollment
- 18 participants (actual)
Primary Outcome Measure
Retention and improvement of visual acuity [ Time Frame: Screening until 1 month after last injection within study eye (Month 12) ]